| HGNC Family | Non-coding RNAs |
| Name | eosinophil granule ontogeny transcript (non-protein coding) |
| Description | Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n EGOT exhibits a dual identity in biomedical research. On one hand, as a long noncoding RNA, EGOT is transcriptionally induced by pathogen‐sensing pathways during viral infections – for example, hepatitis C virus, influenza, and Semliki Forest virus – where it acts as a negative regulator of the interferon‐mediated antiviral response, thereby facilitating viral replication."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In addition, aberrant upregulation of lncRNA EGOT has been reported in human malignancies such as gastric cancer and cirrhotic hepatocellular carcinoma, where its elevated expression correlates with enhanced cell proliferation, cell cycle progression, and poor prognosis, suggesting an oncogenic role"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "and establishing its value within competing endogenous RNA networks."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n On the other hand, EGOT also designates the erythrocyte glutamic oxaloacetic transaminase enzyme—a widely used functional indicator of vitamin B6 (pyridoxine) nutritional status. A substantial body of work has demonstrated that decreased basal EGOT activity and elevated activation coefficients (alpha‐EGOT) reliably reflect a deficiency of vitamin B6 in a variety of clinical settings such as peripheral neuropathy and carpal tunnel syndrome"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", with subsequent studies showing that restoration of EGOT activity after pyridoxine supplementation correlates with clinical improvement"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "and that a low EGOT activity is associated with B6‐deficient diets in diverse populations"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", including university students"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "and dialysis patients."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, the term “EGOT” encompasses both a regulatory lncRNA that modulates antiviral and oncogenic pathways and an enzymatic marker that serves as a sensitive indicator of vitamin B6 status. This duality underscores the multifaceted roles of EGOT in health and disease, highlighting its significance in infectious disease pathogenesis, tumor biology, and clinical nutritional assessment.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Elena Carnero, Marina Barriocanal, Celia Prior, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embr.201541763"}], "href": "https://doi.org/10.15252/embr.201541763"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27283940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27283940"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Wei Peng, Jianzhong Wu, Hong Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA EGOT Promotes Tumorigenesis Via Hedgehog Pathway in Gastric Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Oncol Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12253-017-0367-3"}], "href": "https://doi.org/10.1007/s12253-017-0367-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29209988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29209988"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yuli Zhang, Dinggui Chen, Miaomiao Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anal Cell Pathol (Amst) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2021/5510111"}], "href": "https://doi.org/10.1155/2021/5510111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34258170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34258170"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "C M Byers, J A DeLisa, D L Frankel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pyridoxine metabolism in carpal tunnel syndrome with and without peripheral neuropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Phys Med Rehabil (1984)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "6093733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/6093733"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "J M Ellis, K Folkers, M Levy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Response of vitamin B-6 deficiency and the carpal tunnel syndrome to pyridoxine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (1982)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.79.23.7494"}], "href": "https://doi.org/10.1073/pnas.79.23.7494"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "6961425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/6961425"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "K Folkers, J Ellis, T Watanabe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biochemical evidence for a deficiency of vitamin B6 in the carpal tunnel syndrome based on a crossover clinical study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (1978)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.75.7.3410"}], "href": "https://doi.org/10.1073/pnas.75.7.3410"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "277941"}], "href": "https://pubmed.ncbi.nlm.nih.gov/277941"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "S Shizukuishi, S Nishii, K Folkers "}, {"type": "b", "children": [{"type": "t", "text": "Distribution of vitamin B6 deficiency in university students."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Nutr Sci Vitaminol (Tokyo) (1981)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3177/jnsv.27.193"}], "href": "https://doi.org/10.3177/jnsv.27.193"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "7288513"}], "href": "https://pubmed.ncbi.nlm.nih.gov/7288513"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "E Descombes, O Boulat, F Perriard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Artif Organs (2000)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1525-1594.2000.06553.x"}], "href": "https://doi.org/10.1046/j.1525-1594.2000.06553.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11091166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11091166"}]}]}]}
|
| Synonyms | EGO, NCRNA00190 |
| NCBI Gene ID | 100126791 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
EGOT has 1,809 functional associations with biological entities spanning 7 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 30 datasets.
Click the + buttons to view associations for EGOT from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of EGOT gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of EGOT gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of EGOT gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of EGOT gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of EGOT gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of EGOT gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of EGOT gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with EGOT protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of EGOT gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with EGOT gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at EGOT gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of EGOT gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of EGOT gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with EGOT gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing EGOT from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of EGOT gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of EGOT gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of EGOT gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of EGOT gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of EGOT gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of EGOT gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of EGOT gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of EGOT gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of EGOT gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of EGOT gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of EGOT gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of EGOT gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at EGOT gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of EGOT gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with EGOT protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |